What the trials can tell a reader

Weight change in the main obesity trial

SURMOUNT-1 studied adults who had obesity, or overweight and a related health problem. People with diabetes did not take part.

At 72 weeks, the tirzepatide groups had lost an average of 15.0% to 20.9% of body weight; the placebo group lost 3.1%.

A placebo is a dummy shot used for comparison. The tirzepatide groups received different strengths, so their average weight losses differed.

The drug’s maker supported this trial, which included regular visits and lifestyle counselling.

What happened after stopping

SURMOUNT-4 first gave participants tirzepatide for 36 weeks, then compared continued treatment with a switch to placebo.

At the switch, the study used each person’s weight as a new starting point. Over the next 52 weeks, those on the dummy shot gained an average of 14.0% of that starting weight. This was not 14.0% of the weight they had lost.

Those who kept taking tirzepatide lost another 5.5% on average over that period, also measured from their weight at the switch.

A person’s length of treatment remains a question for their care conversation.

It gives a reason to ask about a longer-term plan before focusing on the first parcel.

Sleep results need their starting point

In SURMOUNT-OSA, participants had obesity as well as obstructive sleep apnea of moderate or severe degree. This means blocked airflow kept interrupting their breathing in sleep.

Their starting average was about 50 breathing interruptions an hour.

After 52 weeks, interruptions fell by about 25 to 29 an hour with tirzepatide and about 5 an hour with placebo.

Many people still had sleep apnea at the end; the trials do not show a cure or a replacement for a breathing machine.

An average leaves room for a question

Ask how closely the people in a study resemble you. Ask what a useful result would mean in your own life. A chart can give context while leaving those questions open.

Take the stopping results into the same conversation as the price. Ask how care would be reviewed if your goals, budget or preferences changed.